Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Innovus Pharmaceuticals Inc

+ Add to Watchlist

INNV:US

0.1789 USD 0.0488 37.51%

As of 20:10:04 ET on 03/30/2015.

Snapshot for Innovus Pharmaceuticals Inc (INNV)

Open: 0.1678 Day's Range: 0.1400 - 0.1800 Volume: 57,445
Previous Close: 0.1301 52wk Range: 0.1105 - 0.5000 1-Yr Rtn: -55.28%

Stock Chart for INNV

No chart data available.
  • INNV:US 0.1789
  • 1D
  • 1M
  • 1Y
0.1301
Interactive INNV Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for INNV

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -0.1900
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 4.79
Shares Outstanding (M) 26.75
30 Day Average Volume 59,694
Price/Book (mrq) 251.6599
Price/Sale (ttm) 5.8252
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for INNV

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for INNV

Innovus Pharmaceuticals, Inc. researches and develops medical drugs. The Company developed and has the right to receive half of the net revenues for the licensing and commercialization of a liver cancer drug, markets an over-the-counter arthritis pain relief cream, and markets an over-the-counter mouth wash.

Bassam B DamajPresident/CEOLynnette DillenExec VP/CFO
Randy BerholtzSecy/Acting General Counsel
More Company Profile & Key Executives for INNV

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil